- Home
- MBLY vs ICLR Comparison
MBLY vs ICLR Comparison
Compare MBLY & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBLY
- ICLR
- Stock Information
- Founded
- MBLY 1999
- ICLR 1990
- Country
- MBLY Israel
- ICLR Ireland
- Employees
- MBLY 3700
- ICLR N/A
- Industry
- MBLY Computer Software: Prepackaged Software
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MBLY Technology
- ICLR Health Care
- Exchange
- MBLY Nasdaq
- ICLR Nasdaq
- Market Cap
- MBLY 15.9B
- ICLR 17.2B
- IPO Year
- MBLY 2022
- ICLR 1998
- Fundamental
- Price
- MBLY $17.39
- ICLR $206.30
- Analyst Decision
- MBLY Buy
- ICLR Strong Buy
- Analyst Count
- MBLY 22
- ICLR 10
- Target Price
- MBLY $24.00
- ICLR $290.60
- AVG Volume (30 Days)
- MBLY 6.3M
- ICLR 1.2M
- Earning Date
- MBLY 01-23-2025
- ICLR 10-23-2024
- Dividend Yield
- MBLY N/A
- ICLR N/A
- EPS Growth
- MBLY N/A
- ICLR 44.49
- EPS
- MBLY N/A
- ICLR 8.99
- Revenue
- MBLY $1,801,000,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- MBLY N/A
- ICLR $3.96
- Revenue Next Year
- MBLY $19.25
- ICLR $2.88
- P/E Ratio
- MBLY N/A
- ICLR $22.72
- Revenue Growth
- MBLY N/A
- ICLR 3.63
- 52 Week Low
- MBLY $10.48
- ICLR $183.38
- 52 Week High
- MBLY $44.48
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- MBLY 68.23
- ICLR 38.31
- Support Level
- MBLY $16.73
- ICLR $202.36
- Resistance Level
- MBLY $20.09
- ICLR $211.76
- Average True Range (ATR)
- MBLY 1.20
- ICLR 6.09
- MACD
- MBLY 0.11
- ICLR 0.64
- Stochastic Oscillator
- MBLY 85.25
- ICLR 9.59
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. Mobileye is the Company's only reportable operating segment. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It also provides data services to Expedite Maintenance Operations with AI-Powered Road Survey Technology.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.